Journal article

Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury

J Glaser, R Gonzalez, VM Perreau, CW Cotman, HS Keirstead

Journal of Neuroscience Research | WILEY | Published : 2004


After spinal cord injury, there is a chemoattractant-mediated inflammatory response that is associated with secondary degeneration. The chemoattractant CXCL10 recruits CD4 Th1 cells via the CXCR3A receptor and inhibits growth and chemotaxis of endothelial cells via the CXCR3B receptor. To test the hypothesis that CXCL10 inhibits angiogenesis following spinal cord injury, we assayed the brainstems and spinal cords of spinal cord-injured mice treated with anti-CXCL10 antibodies for expression of angiogenesis-associated genes and quantified blood vessels within their spinal cords. Brainstem microarray analysis indicated eight angiogenesis-associated genes that had significantly higher expressio..

View full abstract